IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice

scientific article published on 01 October 1997

IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9378984

P2093author name stringOkamura H
Hayashi N
Nakanishi K
Matsui K
Tsutsui H
Hyodo Y
Higashino K
Kawada N
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectendotoxinsQ319997
P304page(s)3961-3967
P577publication date1997-10-01
P1433published inJournal of ImmunologyQ3521441
P1476titleIL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice
P478volume159

Reverse relations

cites work (P2860)
Q50295997A Prominent Role of Interleukin-18 in Acetaminophen-Induced Liver Injury Advocates Its Blockage for Therapy of Hepatic Necroinflammation
Q36369443A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production
Q34120400A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model
Q74441357Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18
Q75253670Advances in alcoholic liver disease
Q37233638Advances in sepsis-associated liver dysfunction
Q87106515Anti-inflammatory and antiapoptotic effect of interleukine-18 binding protein on the spinal cord ischemia-reperfusion injury
Q35645186Association between interleukin-18 gene promoter (- 607C/A and - 137G/C) polymorphisms and chronic hepatitis C virus infections: A meta-analysis
Q35559075Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory fa
Q35064491CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue
Q42091407Changes of inflammation-associated cytokine expressions during early phase of experimental endotoxic shock in macaques
Q38058384Clinical review: The liver in sepsis
Q37148152Cytokines in cancer immunotherapy
Q91719352Dietary fish oil supplementation alters liver gene expressions to protect against LPS-induced liver injury in weanling piglets
Q47417555Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus
Q27489815Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis
Q27472836Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity
Q35362225IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner
Q35086936IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism
Q36704236IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils
Q54409335Immune responses induced by DNA vaccines bearing Spike gene of PEDV combined with porcine IL-18.
Q37579232Immunomodulatory Effects of Adipose Tissue-Derived Stem Cells on Concanavalin A-Induced Acute Liver Injury in Mice
Q38209856Importance of Kupffer cells in the development of acute liver injuries in mice
Q61799800Inflammasome Genes' Polymorphisms in Egyptian Chronic Hepatitis C Patients: Influence on Vulnerability to Infection and Response to Treatment
Q37699536Inflammasomes in Inflammation-Induced Cancer
Q28344924Initiation of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6 mice
Q60718595Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients
Q90050665Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases
Q79902450Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill
Q37191434Interleukin-18-related genes are induced during the contraction phase but do not play major roles in regulating the dynamics or function of the T-cell response to Listeria monocytogenes infection
Q34117131Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses.
Q33883398Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesion
Q35056090Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18.
Q82059161Liver injury and abscess formation in secondary murine peritonitis
Q36439183Mechanisms of drug-induced liver injury.
Q53643436Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection.
Q40936325Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin
Q28367598Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18
Q28510726Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice
Q78601709Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease
Q39865381Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells
Q39515412Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection
Q34582310Present concepts on the inflammatory modulators with special reference to cytokines
Q33205953Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide
Q27488349Regulatory Polymorphisms in the Interleukin‐18 Promoter Are Associated with Hepatitis C Virus Clearance
Q34002652Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections
Q38402599Role of interleukin-18 in modulation of oral carcinoma cell proliferation
Q43005209Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo
Q82988703Significance of elevated serum IL-18 levels in patients with acute pancreatitis
Q36732698T-cell activation in the intestinal mucosa
Q41118007TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance
Q33996553The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice
Q54253587The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.
Q92977915The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity
Q35119764Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis

Search more.